1. A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus. (December 2018) Authors: Shestakova, Marina V.; Wilding, John P.H.; Wilpshaar, Wim; Tretter, Reiner; Orlova, Valeria L.; Verbovoy, Andrey F. Journal: Diabetes research and clinical practice Issue: Volume 146(2018) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A systematic review of interventions to increase physical activity and reduce sedentary behaviour following bariatric surgery. (June 2022) Authors: James, Jennifer D.; Hardeman, Wendy; Goodall, Mark; Eborall, Helen; Sprung, Victoria S.; Bonnett, Laura J.; Wilding, John P.H. Journal: Physiotherapy Issue: Volume 115(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adipocytes in obesity: A perfect reservoir for SARS-CoV-2?. (February 2023) Authors: Zhu, JingJing; Wilding, John P.H.; Hu, Ji Journal: Medical hypotheses Issue: Volume 171(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular outcome trials in obesity: A review. (7th September 2020) Authors: Wilding, John P.H.; Jacob, Stephan Journal: Obesity reviews Issue: Volume 22:Number 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. Issue 8 (25th August 2020) Authors: Bonaca, Marc P.; Wiviott, Stephen D.; Zelniker, Thomas A.; Mosenzon, Ofri; Bhatt, Deepak L.; Leiter, Lawrence A.; McGuire, Darren K.; Goodrich, Erica L.; De Mendonca Furtado, Remo Holanda; Wilding, John P.H.; Cahn, Avivit; Gause-Nilsson, Ingrid A.M.; Johanson, Per; Fredriksson, Martin; Johansson,... Journal: Circulation Issue: Volume 142:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes. Issue 1 (January 2019) Authors: Proietto, Joseph; Lau, David C.W.; Fujioka, Ken; Greenway, Frank; O'Neil, Patrick; Wilding, John P.H.; Jacobsen, Peter B.; Skjøth, Trine V.; Madsbad, Sten; O'Moore-Sullivan, Trisha Journal: Obesity research & clinical practice Issue: Volume 13:Issue 1(2019) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial. Issue 15 (14th April 2020) Authors: Zelniker, Thomas A.; Bonaca, Marc P.; Furtado, Remo H.M.; Mosenzon, Ofri; Kuder, Julia F.; Murphy, Sabina A.; Bhatt, Deepak L.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John P.H.; Budaj, Andrzej; Kiss, Robert G.; Padilla, Francisco; Gause-Nilsson, Ingrid; Langkilde, Anna Maria; Raz, Itam... Journal: Circulation Issue: Volume 141:Issue 15(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. Issue 22 (28th May 2019) Authors: Kato, Eri T.; Silverman, Michael G.; Mosenzon, Ofri; Zelniker, Thomas A.; Cahn, Avivit; Furtado, Remo H.M.; Kuder, Julia; Murphy, Sabina A.; Bhatt, Deepak L.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John P.H.; Bonaca, Marc P.; Ruff, Christian T.; Desai, Akshay S.; Goto, Shinya; Johansso... Journal: Circulation Issue: Volume 139:Issue 22(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial. Issue 21 (5th May 2022) Authors: Furtado, Remo H.M.; Raz, Itamar; Goodrich, Erica L.; Murphy, Sabina A.; Bhatt, Deepak L.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John P.H.; Aylward, Philip; Dalby, Anthony J; Dellborg, Mikael; Dimulescu, Doina; Nicolau, José C.; Oude Ophuis, Anthonius J.M.; Cahn, Avivit; Mosenzon, Ofri... Journal: Circulation Issue: Volume 145:Issue 21(2022) Page Start: 1581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Liraglutide 3.0 mg in obese/overweight adults with or without prediabetes with baseline BMI <35 vs ≥35 kg/m2 in the SCALE Obesity and Prediabetes 56-week randomized, double-blind, placebo-controlled trial. Issue 1 (January 2019) Authors: Proietto, Joseph; Pi-Sunyer, Xavier; van Gaal, Luc; Wilding, John P.H.; Roux, Carel W. Le; Lilløre, Søren K.; Claudius, Birgitte; Greenway, Frank; Haywood, Cilla Journal: Obesity research & clinical practice Issue: Volume 13:Issue 1(2019) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗